4reverse splits
1-for-531 cumulative
+1142.2%share growth, 1-year
XBRL EDGAR
43.5M → 40.5Mshares issued (XBRL history)
Fresh Supplyfiling state
424B filed ~14d ago

Case Notes

China Pharma Holdings, Inc. has 4 reverse splits on record — cumulative 1-for-531. Its share count grew 1142.2% over the last twelve months per XBRL EDGAR data.

Most recent stress filing: 10-Q on 2026-05-18, flagging Going concern. 1 supply registration (S-1/424B) landed in the last 12 months.

Registered shares exist to be sold — that is what the S-1 and 424B instruments document. In our research across this filing posture, freshly registered supply is the loaded state of the cycle: the paperwork has created the legal right to place shares into the market. That is not a prediction — it is what the filings say is possible.

Share Count Over Time

XBRL cover-page share counts from SEC EDGAR filings. Amber dashed lines mark reverse-split dates. 4 reverse splits on record.

Reverse Split Log

Each event consolidates shares — fewer shares, same market cap. Source: EDGAR corporate actions.

2023-03-061-for-9.7
2024-03-061-for-5.2
2025-04-151-for-10.5
2026-07-221-for-0.2

Cumulative effective ratio: 1-for-531— a share held at inception is now worth 1/531 of its original fraction.

Filing Stress Record

Stress-language flags extracted from SEC EDGAR 10-K/10-Q filings. Score 1–10 reflects language intensity.

DateFormScoreFlags
2024-08-1510-Q1/10Going concern
2024-11-1410-Q1/10Going concern
2025-04-0110-K2/10Going concernSplit intent
2025-05-1510-Q2/10Going concernSplit intent
2025-08-1510-Q2/10Going concernSplit intent
2025-11-1310-Q1/10Going concern
2026-04-0210-K2/10Going concernSplit intent
2026-05-1810-Q1/10Going concern

Source: public EDGAR records.

424B Supply Pulse

Prospectus supplements (424B5) filed registering shares for resale — each bar is one month with a filing. Bars above average signal active distribution windows. Source: SEC EDGAR.

12 12 07
2021-122024-122026-07

← Back to Registry